# AI_TRANSPARENCY_PROTOCOL.md  
**MedIntel Clinical AI Transparency & Disclosure Framework**

---

## 1. Purpose

This document defines the **mandatory transparency requirements** for all AI systems operating within the MedIntel repository.  
Its purpose is to ensure that AI behavior, limitations, and outputs are **understandable, auditable, and appropriately disclosed** to authorized stakeholders without compromising safety, security, or intellectual integrity.

Transparency is treated as a **clinical safety control**, not a marketing feature.

---

## 2. Scope

This protocol applies to:
- All MedIntel AI models (development, validation, deployment, post-market)
- All AI-generated outputs used in clinical or RPM contexts
- All human-facing interfaces that surface AI recommendations or alerts
- All regulatory, audit, and oversight interactions involving AI behavior

---

## 3. Transparency Principles

MedIntel transparency operates under the following principles:

- **Clinical Primacy:** Transparency must support safe clinical decision-making
- **Role-Appropriate Disclosure:** Not all users receive the same level of detail
- **Bounded Explainability:** Explanations must not create false certainty
- **Auditability Over Interpretability:** Traceability is mandatory even where interpretability is limited
- **No Hidden Automation:** AI influence must never be concealed

---

## 4. Mandatory Disclosure Elements

All active AI models must disclose, at minimum:

- Model purpose and intended clinical use
- Advisory (non-autonomous) status
- Current model version
- Training data category summary (not raw data)
- Primary performance metric(s)
- Known limitations and contraindicated uses
- Confidence or uncertainty signal associated with outputs

---

## 5. Decision-Level Transparency

For every AI-generated output presented to a clinician:

The system must provide:
- Clear identification that the output is AI-generated
- Confidence score or uncertainty band
- Primary factors contributing to the recommendation (where applicable)
- Timestamp and model version
- Reference to supporting data window (RPM or clinical context)

Opaque outputs without attribution are prohibited.

---

## 6. Role-Based Transparency Access

| Role | Transparency Level |
|-----|--------------------|
| Clinician | Decision rationale, confidence, limitations |
| Researcher | Aggregate model behavior and performance |
| Auditor | Full traceability and lifecycle artifacts |
| Regulator | Safety case–aligned transparency view |
| Patient | Plain-language explanation only |
| Public | High-level system disclosures |

Unauthorized access to deeper transparency layers is prohibited.

---

## 7. Explainability Boundaries

MedIntel explicitly prohibits:
- Fabricated explanations
- Over-simplified rationales implying determinism
- Disclosure of proprietary weights or raw training data
- Post-hoc explanations that contradict validated behavior

Explainability must reflect **validated system behavior**, not narrative convenience.

---

## 8. Transparency During Model Change

Any model update must:
- Update transparency artifacts concurrently
- Trigger re-validation of disclosed metrics
- Preserve historical transparency records
- Surface version changes to clinicians before use

Silent transparency drift is a governance breach.

---

## 9. Incident and Dispute Transparency

During incidents, overrides, or disputes:
- All AI outputs involved must remain viewable
- Explanation artifacts must be preserved
- Transparency data may not be altered retroactively
- Access is expanded for oversight bodies only

---

## 10. Transparency and DAO Governance

DAO governance actions affecting AI systems must:
- Reference transparency artifacts
- Preserve public rationale where safe
- Avoid redacting safety-relevant information
- Respect restricted disclosures defined by law

---

## 11. Regulatory Alignment

This protocol aligns with:
- EU AI Act (Transparency & Human Oversight)
- FDA GMLP principles
- WHO AI ethics guidance
- ISO/IEC 23894 (AI risk management)
- Clinical decision support regulations

---

## 12. Enforcement

Non-compliance with this protocol results in:
- Immediate model suspension
- Mandatory governance review
- Potential regulator notification
- Permanent audit flagging

Transparency violations are treated as **clinical safety events**.

---

## 13. Recordkeeping

All transparency artifacts are:
- Version-controlled
- Timestamped
- Immutable once published
- Retained for the full system lifecycle

---

### Status  
**Active – Binding MedIntel Governance Instrument**

